Compared to mock infection, both IAV infection and rIL-17A treatment significantly decreased ZO-1 expression (Fig 5F) and increased the basolateral transfer of FITC-dextran to the basal transwell chamber (Fig 5G). The gene discussed is TJP1; the disease is infection.